IRONWOOD PHARMACEUTICALS INC·4

Nov 10, 4:03 PM ET

Consylman Gina 4

4 · IRONWOOD PHARMACEUTICALS INC · Filed Nov 10, 2020

Insider Transaction Report

Form 4
Period: 2020-11-09
Consylman Gina
Chief Accounting Officer
Transactions
  • Sale

    Class A Common Stock

    2020-11-09$10.92/sh825$9,009270,289 total
  • Sale

    Class A Common Stock

    2020-11-09$10.92/sh590$6,443269,699 total
Footnotes (2)
  • [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on December 16, 2016.
  • [F2]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on January 2, 2018.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION